Xiang and collaborators demonstrated that IL-17 in ovarian cancer is produced by CD4+ T cells and CD68+ macrophages, tumor-associated macrophages (TAM) in the ovarian CSC niche, and the IL-17 receptor is expressed in a population of CD133+ CSCs [41]. Here, CD4 is linked to ovarian carcinoma.